Suchergebnisse - "Halfmann, Peter J"

PubPharm (6)

1

Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2

enthalten in: Journal of medical virology | 2023

von Sakai-Tagawa, Y. | Yamayoshi, S. | Halfmann, P. | +11

2

Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate

enthalten in: The Lancet. Infectious diseases | 2023

von Uraki, R. | Ito, M. | Kiso, M. | +16

3

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB

enthalten in: The New England journal of medicine | 2023

von Imai, M. | Ito, M. | Kiso, M. | +10

4

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

enthalten in: Nature | 2022

von Uraki, R. | Kiso, M. | Iida, S. | +66

UpdateOf: Res Sq. 2022 Feb 24;:. - PMID 35233565

5

Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron

enthalten in: Cell reports | 2022

von Chong, Z. | Karl, C. | Halfmann, P. | +6

UpdateOf: bioRxiv. 2022 Jan 24;:. - PMID 35118466

6

Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model

enthalten in: mBio | 2021

von Chiba, S. | Kiso, M. | Nakajima, N. | +15

1
[1]